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To report longitudinal clinical, EEG, and MRI findings in 2 sisters carrying compound het-
erozygous ARV1 mutations and exhibiting a peculiar form of developmental and epileptic
encephalopathy (DEE). Neuropathologic features are also described in one of the sisters.
Methods
Clinical course description, video-EEG polygraphic recordings, brain MRI, skin and muscle
biopsies, whole-exome sequencing (WES), and brain neuropathology.
Results
Since their first months of life, both girls exhibited severe axial hypotonia, visual inattention,
dyskinetic movements, severe developmental delay, and slow background EEG activity. In-
tractable nonmotor seizures started in both at the eighth month of life, exhibiting the elec-
troclinical characteristics of epilepsy of infancy with migrating focal seizures (EIMFS). In the
second year of life, continuous epileptiform EEG activity of extremely high amplitude appeared
in association with myoclonic status, leading to severely impaired alertness and responsiveness.
Repeated brain MRI revealed progressive atrophic changes and severe hypomyelination. WES
identified a compound heterozygous in the ARV1 gene [(p.Ser122Glnfs*7) and (p.Trp163*)]
in one patient and was subsequently confirmed in the other. Both sisters died prematurely
during respiratory infections. Postmortem neuropathologic examination of the brain, per-
formed in one, revealed atrophic brain changes, mainly involving the cerebellum.
Conclusions
This report confirms that biallelic ARV1 mutations cause a severe form of DEE and adds
epilepsy with migrating focal seizures and myoclonic status to the spectrum of epilepsy phe-
notypes. Considering the potential role of human ARV1 in glycosylphosphatidylinositol (GPI)
anchor biosynthesis, this severe syndrome can be assigned to the group of inherited GPI
deficiency disorders, with which it shares remarkably similar clinical and neuroimaging features.
ARV1 should be considered in the genetic screening of individuals with EIMFS.
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The ARV1 gene encodes for Acyl-CoA cholesterol acyl
transferase–related enzyme 2 required for viability 1
(ARV1), which is a highly conserved protein located in the
endoplasmic reticulum membrane. Although extensive
functional studies in yeasts and mice have explored the
consequences of ARV1 mutations,1-4 the association of
biallelic mutations of this gene with human disease is lim-
ited to a few individuals exhibiting early infantile epileptic
encephalopathy, with intractable seizures and severe de-
velopmental delay.5-8
In 1 patient, the epilepsy phenotype featured drug-resistant
multifocal clustered seizures, disorganized background EEG
activity, and modified hypsarrhythmia5; in the remaining
children, details on the epileptic encephalopathy were not
provided.
We describe 2 sisters carrying compound heterozygous ARV1
mutations and exhibiting an early-onset epileptic encepha-
lopathy with peculiar electroclinical features.
Case Description
Patient 1
Patient 1 is a first-born girl with nonconsanguineous parents
who was delivered by elective C-section at 36 + 5 gestational
weeks. Her birth weight was 2650 g (50th percentile), length
46 cm (25th percentile), head circumference 32.7 cm, (40th
percentile), and Apgar Index 8/9.
At 4 months, hypotonia was noticed, with dyskinetic move-
ments, opisthotonus posturing, and absence of eye tracking.
Figure 1 Patient 1. Focal Seizure With a Migrating Pattern
Top: note on the right hemisphere the progressive onset of an ictal discharge of fast polyspikeswaves involvingmainly the temporo-parietal regions related to
psychomotor arrest and flushing. A few seconds later, a similar discharge independently appears on the left parieto-temporal region, associated with
increasing lip cyanosis and drooling. Bottom: a few seconds later, erratic mild myoclonic jerks appear involving mainly the face. At the end of the left-sided
ictal event, the child sneezes; the seizure lasts a few more seconds on the right hemisphere.
Glossary
DEE = developmental and epileptic encephalopathy; EIMFS = epilepsy of infancy with migrating focal seizure; ER =
endoplasmatic reticulum; GPI = glycosylphosphatidylinositol; WES = whole-exome sequencing.
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At 6 months, severe axial hypotonia, abnormal movements,
and absent eye fixation persisted. EEG showed slow high-
amplitude background activity (>400 μV), replaced 1 month
later by subcontinuous high-amplitude multifocal spikes and
waves on both hemispheres.
From age 8 months, multiple per-day focal nonmotor seizures
started, with unresponsiveness, chewing automatisms, and per-
ioral cyanosis, lasting less than a minute. Despite treatment with
valproate, at age 12 months, seizures increased in frequency,
appearing at times in clusters, showing multifocal origin and
involving either hemisphere with a migrating pattern (figure 1),
prompting repeated intensive care unit admissions. Transition
from focal seizures to hemiclonic status was often seen, especially
during fever (figure 2). Polygraphic EEG recordings revealed an
unusual pattern of myoclonic status featuring subcontinuous
rhythmic or arrhythmic spikes and slow waves of very high
amplitude, associated with reduced responsiveness and erratic
myoclonus predominating in the arms and face. During sleep,
myoclonus disappeared, but the abnormal EEG pattern
remained subcontinuous (figure 3A).
Myoclonic status and clustered multifocal seizures persisted
despite several pharmacologic trials (including phenobarbital,
phenytoin, ethosuximide, levetiracetam, carbamazepine, and
hydrocortisone). Only the ketogenic diet reduced seizure
frequency for 10 consecutive months, from several per-day to
monthly clusters triggered by fever, remission of myoclonic
status episodes, and improved awareness.
By age 3 years, head growth dropped to below the third
percentile, and the overall clinical picture worsened because of
almost continuous focal seizures and myoclonic status (figure
3B), with recurrent respiratory infections, leading to demise at
4 years 2 months due to bronchopneumonia during status
epilepticus. No clinical or electrocardiographic signs of car-
diomyopathy were noticed.
Extensive biological and metabolic investigations on urine,
blood and CSF, karyotype, Comparative Genomic Hybridiza-
tion array (CGH-array), histologic and ultrastructural exami-
nation of skin and muscle biopsy, and study of mitochondrial
respiratory chain enzymes were all unrevealing. Eye fundus,
sensitive evoked potential (SEP), and ERG persisted in normal
limits, whereas visual evoked potentials (VEP) progressively
extinguished. BrainMRI, performed at 4 months, showed a thin
corpus callosum (figure 4A). A second MRI, at 24 months,
showed mild brain atrophy, mainly involving the right temporal
Figure 2 Patient 1. Hemiclonic Seizure
On the top: during an ictal discharge of polyspikes and waves with intermixed fast activity involving the right centro-parietal region, associated with rhythmic
jerks of the left arm, a similar ictal discharge independently involves the left temporo-occipital region and is associated with eye deviation to the right, lip
cyanosis, and intense tachycardia. On the bottom: cyanosis and tachycardia resolve only at the end of the left temporal discharge, which lasts longer than that
involving the right hemisphere.
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lobe, hypomyelination, and cerebellar atrophy, more severely
affecting the vermis (figure 4B–D).
Postmortem examination identified the cause of death with
acute respiratory distress syndrome and a hypertrophic car-
diomyopathy with subvalvular stenosis. Brain neuropathology
documented cerebral atrophy, more severe in the right tem-
poral lobe, with concomitant Ammon horn sclerosis and ab-
normal morphology of the parahippocampal gyrus. The corpus
callosum was thin and the cerebellum atrophic, with reduced
cortical thickness, especially in the vermis. The cytoarchitec-
tonic organization of the cerebral cortex was normal, whereas
severe and diffuse loss of Purkinje cells was present in the
cerebellar cortex, with dystrophic dendrites in the molecular
layer, cell rarefaction in the inner granular layer, and Bergmann
gliosis. There was, in addition, an abnormal organization of the
dentate gyri bilaterally, with mild gliosis. Subcortical gray nu-
clei, brainstem, and the spinal cord were normal.
Patient 2
Patient’s one younger sister was born at 37 gestational weeks,
following an uneventful pregnancy; at birth, her weight was
3,210 g (75° percentile), and head circumference was 34.7 cm
(75° percentile).
Figure 3 Patient 1. Myoclonic Status
(A) Note on the EEG during wakefulness, subcontinuous, diffuse high-amplitude spike waves intermingled with polyspikes, synchronous, and asynchronous
on the hemispheres, associated with subcontinuous erratic myoclonic jerks, partially masked by dyskinetic movements. During sleep, continuous EEG
discharges persist in the absence of recognizable physiologic elements, whereas motor manifestations disappear. (B) Note on the EEG the continuous SW of
very high amplitude, involving both hemispheres, accompanied on EMG channels by rhythmic but bilaterally asynchronous myoclonic activity.
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Severe axial hypotonia, with opisthotonos posturing and jitteri-
ness, resulting in a hypotonic-dyskinetic quadriparesis was already
apparent at 4months (figure 5A). Visual pursuit was poor; ocular
fundus examination, VEPs, and SEPs were normal. Head growth
slowed down to around the 3rd percentile before age 2 years.
From age 8 months, the girl exhibited multiple seizures per
day. Video-EEG recordings captured focal ictal activity arising
independently from the centro-temporal-parietal regions of
either hemisphere (video 1) causing psychomotor arrest,
apnea, cyanosis, deviated gaze, and lasting 30–60 seconds.
Prolonged focal motor seizures triggered by fever at times
evolved as hemiclonic status epilepticus. Interictal EEG ac-
tivity was of high amplitude (>400 μV), intermingled with
multifocal discharges. Phenobarbital was ineffective; the ke-
togenic diet, started at 11 months, determined a temporary
reduction in seizure frequency. Seizures remained un-
controlled, and at 18 months, polygraphic EEG recordings
documented the same peculiar myoclonic status epilepticus
observed in this patient’s sister (figure 5B). Dilated cardio-
myopathy with partial hemodynamic decompensation was
diagnosed. ECG documented I- and II-degree atrioventricular
block, and physical examination showed hepatosplenomegaly.
During follow-up, head growth slowed down to below the 3rd
percentile. The frequency of focal seizures decreased to one
cluster per month, mostly during fever; myoclonic status
remained unchanged (figures 5C,5D) until demise, at age 9
years during pneumonia.
Brain MRI, performed at 7 months, showed a thin corpus
callosum. A new MRI, at age 3 years, showed a mildly
atrophic cerebellar vermis, a small right hippocampus, and
hypomyelination (figure 4E–G). At age 8 years, atrophic changes
were more obvious, mainly involving the cerebellum
(figure 4H).
Whole-exome sequencing, performed in patient 2 at age 8
years, identified compound heterozygous mutations in the
ARV1 gene (NM_022786.3), c.363_364del
(p.Ser122Glnfs*7) inherited from the mother, and c.489 G >
A (p.Trp163*) inherited from the father. Sanger sequencing,
performed in a DNA sample from formalin-fixed paraffin-
embedded brain tissue of patient 1, confirmed both muta-
tions. The p.Ser122Glnfs*7 mutation is present in the gno-
mAD control database (gnomad.broadinstitute.org/) with a
frequency of 4/250,498 alleles and is not reported in the
Human Gene Mutation Database (HGMD) (portal.biobase-
international.com/hgmd/pro/start.php). The p.Trp163*
mutation is not present in the gnomAD control database
(gnomad.broadinstitute.org/) and in the HGMD mutation
database (portal.biobase-international.com/hgmd/pro/start.
php). Both mutations introduce a premature stop codon in
the mRNA and are predicted to elicit a rapid degradation of
the ARV1 mRNA through nonsense-mediated mRNA decay.
The MutationTaster (mutationtaster.org/) tool predicts both
mutations to be disease causing. We classified both mutations
as pathogenic according to the international guidelines of the
ACMG Laboratory Practice Committee Working Group.9
Figure 4 MRI Findings of Two Patients
Patient 1: (A) Sagittal T1W section showing a thin corpus callosum. (B) Coronal T1W section showing signs of mild atrophymainly involving the right temporal
lobe, which shows gyral simplification and a dilated temporal horn. (C) T2W axial section showing high signal intensity of the white matter, consistent with
hypomyelination. (D) Sagittal T1W section showing atrophy of the cerebellar vermis. Patient 2: (E) Sagittal T1W section showing a thin corpus callosum and a
mildly atrophic cerebellar vermis. (F) Coronal T1W image showing signs of mild atrophymainly involving the right temporal lobe, which shows enlarged sulci
and a dilated temporal horn. (G) T2Waxial section showing high signal intensity of thewhitematter, consistent with hypomyelination. (H) Sagittal T1W section
showing more severe atrophy of the cerebellar vermis.
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Data Availability
The data that support the findings of this study are available
on request from the corresponding author. The data are not
publicly available because of privacy or ethical restrictions.
Discussion
These 2 sisters were compound heterozygous for the
p.Ser122Glnfs*7 and the p.Trp163* truncating mutations and
exhibited severe clinical features that overlap with those de-
scribed in patients with ARV1-related encephalopathy, all
harboring homozygous variants. Indeed, both truncating
ARV1 mutations found in our patients are predicted to result
in loss of function, the molecular mechanism known to be
associated with ARV1 deficiency, both in humans and mice.5,8
ARV1, mapping to 1q42.2, encodes for a transmembrane
protein of endoplasmatic reticulum (ER) implied in sterol
homeostasis in eukaryotic cells, with a role in sterol transport
between the ER and plasmatic membrane.3 As already stated,5
because of its implication in glycosylphosphatidylinositol
(GPI)-anchor synthesis,10,11 ER stress induced by accumu-
lation of immature GPI-anchored proteins or aberrant lipid
metabolism may be responsible for the diseases associated
with ARV1 deficiency.11
Figure 5 Patient 2. Abnormal Background Activity and Myoclonic Status
(A) Note on the EEG the unusually slow and high-amplitude poorly modulated theta-delta activity on the parieto-occipital regions and on the EMG the
abnormal dyskinetic movements. (B) Note on the EEG continuous, diffuse, high-amplitude (about 400 μV) epileptiform activity associating polyspike-waves
and a diffuse very fast activity related to continuous rhythmic jerks. This electroclinical picture remains unchanged throughout the evolution (C) up to 9 years
(D).
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Evidence of a genetic syndrome resulting from deficiency of
ARV1 in humans is currently based on the description of 14
patients from 5 families, all harboring homozygous variants.
The overall common reported clinical features include severe
developmental delay and intractable seizures with onset in the
first year of life in all and seizure onset within the 6th months
in 50%. Additional clinical features included poor head con-
trol (10/14), hypotonia (8/14), visual impairment (9/14),
and dystonia (6/14). Seven patients died prematurely because
of respiratory infections or aspiration pneumonia, mostly
during status epilepticus (1–5 years). Six remaining patients
were still alive at last follow-up, between age 2 years 5 months
and 18 years.5-8 Progressive deceleration of head growth is
reported in 5 patients and mild-moderate dilated cardiomy-
opathy in 2.7
Reported MRI findings include cerebellar atrophy in 3 in-
dividuals, delayed myelination in 2, a thin corpus callosum
in 1, and a hyperintense signal on T2-weighted with re-
stricted diffusion in the cerebral central tegmental tract in
one.5,7,8 No MRI abnormalities were observed in 2 indi-
viduals aged 7 months and 3 years, respectively.7,8 Overall,
reported clinical features are similar to those observed in
our patients, who harbored compound heterozygous
variants.
In the 2 sisters we describe, severe axial hypotonia,
dystonic/dyskinetic movements, poor visual contact, and
head growth deceleration were already manifested a few
weeks after birth and, from the third to the fourth month
of life, subcontinuous myoclonic jerks intermingled to
dyskinetic movements appeared. The associated electro-
clinical picture was quite distinctive, consisting of in-
tractable migrating focal motor and nonmotor seizures12,13
and a peculiar myoclonic status mainly involving the face
and upper limbs, resembling the electroclinical syndrome
known as myoclonic status of nonprogressive epileptic
encephalopathies.14,15 The overall neurologic condition
progressively worsened, leaving both girls severely hypo-
tonic, with almost continuous abnormal movements, poor
eye contact, absent speech, profound intellectual disability,
and recurrent respiratory infections. The older girl was af-
fected by dilated myocardiopathy, and her sister exhibited
left ventricular hypertrophy, which was documented at
autopsy not to be associated with abnormalities of the
myocardial tissue.
Brain MRI findings in both patients documented malforma-
tive characteristics in association with progressive cerebellar
atrophy. The association of these findings favors the hy-
pothesis of a GPI-anchor–related disorder, which plays a key
role in embryogenesis, neurogenesis, and synaptic forma-
tion.16 To additionally support this hypothesis, the core
symptoms of patients with ARV1 deficiency reported pre-
viously5 and in our study, are also seen in inherited GPI
deficiency conditions.17-20 Of note, migrating focal seizures,
dilated cardiomyopathy, and fever sensitivity can also be
found in both of these conditions.21,22
This report confirms the evidence for an autosomal recessive
early-onset developmental and epileptic encephalopathy
(DEE) caused by biallelic ARV1 mutations in humans and
describes the first family with compound heterozygous mu-
tations. It also suggests that ARV1 mutations should be con-
sidered a possible cause of epilepsy of infancy with migrating
focal seizures.
Considering the potential role of human ARV1 in GPI-anchor
biosynthesis, this genetic syndrome could be considered in
the group of inherited GPI deficiency disorders.19,20,22,23
This syndrome epitomizes difficulties in sharply parting
the category of the DEEs from that of the progressive
neurologic disorders at the early stages of clinical di-
agnosis. Such dichotomous classification is obviously un-
satisfactory when applied to peculiar clinical features such
as those reported in this study, in which the combination of
severe neurologic impairment and almost continuous ep-
ileptic activity makes it difficult to identify the main de-
terminants of clinical presentation. The DEE category in
this context is more a tentative broad category awaiting
diagnostic finalization.
Study Funding
No targeted funding reported.
Disclosure
The authors report no disclosures. Go to Neurology.org/NG
for full disclosures.
Publication History








Major role in the acquisition of data;
designed and conceptualized the study;
analyzed the data; and drafted the





Acquisition of data; analyzed the data;
drafted the manuscript for intellectual





Interpreted the data and revised the





Performed genetic test; interpreted
genetic data; and revised the





Performed genetic test; interpreted
genetic data; and revised the
manuscript
Continued
Neurology.org/NG Neurology: Genetics | Volume 7, Number 3 | June 2021 7
References
1. Tinkelenberg AH, Liu Y, Alcantara F, et al. Mutations in yeast ARV1 alter intracellular
sterol distribution and are complemented by human ARV1. J Biol Chem. 2000;
275(52):40667-40670.
2. Shechtman CF, Henneberry AL, Seimon TA, et al. Loss of subcellular lipid transport
due to ARV1 deficiency disrupts organelle homeostasis and activates the unfolded
protein response. J Biol Chem. 2011;286(14):11951-11959.
3. Georgiev AG, Johansen J, Ramanathan VD, Sere YY, Beh CT, Menon AK. Arv1
regulates PM and ER membrane structure and homeostasis but is dispensable for
intracellular sterol transport. Traffic. 2013;14(8):912-921.
4. Lagor WR, Tong F, Jarrett KE, et al. Deletion of murine Arv1 results in a lean
phenotype with increased energy expenditure. Nutr Diabetes. 2015;5(10):e181.
5. Palmer EE, Jarrett KE, Sachdev RK, et al. Neuronal deficiency of ARV1 causes an auto-
somal recessive epileptic encephalopathy. Hum Mol Genet. 2016;25(14):3042-3054.
6. Alazami AM, Patel N, Shamseldin HE, et al. Accelerating novel candidate gene dis-
covery in neurogenetic disorders via whole-exome sequencing of prescreened mul-
tiplex consanguineous families. Cell Rep. 2015;10(2):148-161.
7. Segel R, Aran A, Gulsuner S, et al. A defect in GPI synthesis as a suggested mechanism for
the role of ARV1 in intellectual disability and seizures. Neurogenetics. 2020;21(4):259-267.
8. Davids M, Menezes M, Guo Y, et al. Homozygous splice-variants in human ARV1
cause GPI-anchor synthesis deficiency. Mol Genet Metab. 2020;130(1):49-57.
9. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of
sequence variants: a joint consensus recommendation of the American College of
Medical genetics and genomics and the association for molecular pathology. Genet
Med. 2015;17(15):405-424.
10. Kajiwara K, Watanabe R, Pichler H, et al. Yeast ARV1 is required for efficient delivery of an
early GPI intermediate to the first mannosyltransferase during GPI assembly and controls
lipid flow from the endoplasmic reticulum.Mol Biol Cell. 2008;19(5):2069-2082.
11. Ikeda A, Kajiwara K, Iwamoto K, et al. Complementation analysis reveals a potential
role of human ARV1 in GPI anchor biosynthesis. Yeast. 2016;33(2):37-42.
12. Coppola G, Plouin P, Chiron C, Robain O, Dulac O.Migrating partial seizures in infancy: a
Malignant disorder with developmental arrest. Epilepsia. 1995;36(10):1017-1024.
13. Caraballo RH, Fontana E, Darra F, et al. Migrating focal seizures in infancy: analysis of
the electroclinical patterns in 17 patients. J Child Neurol. 2008;23(5):497-506.
14. Dalla Bernardina B, Fontana E, Darra F. Myoclonic status in nonprogressive en-
cephalopathies. Adv Neurol. 2005;95(50 suppl 5):59-70.
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